Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Mid-Cap

Are you an investor looking for mid-capitalization with sound fundamentals, earnings potential and possibly dividend paying? You are at the right place!

|
A Defensive Pharma Play Is Back in Focus - Hikma Pharmaceuticals (HIK)
Team Kalkine

A Defensive Pharma Play Is Back in Focus - Hikma Pharmaceuticals (HIK)

  • Jan 20, 2026
  •   | Read Time : 10 Mins
MNDI - Is Mondi Stock Undervalued After the Paper Sell-Off?
Team Kalkine

MNDI - Is Mondi Stock Undervalued After the Paper Sell-Off?

  • Jan 19, 2026
  •   | Read Time : 10 Mins
SCT - Softcat Lifts Guidance as Cloud and Security Orders Accelerate
Team Kalkine

SCT - Softcat Lifts Guidance as Cloud and Security Orders Accelerate

  • Jan 19, 2026
  •   | Read Time : 10 Mins
Is Croda Stock Undervalued After the Specialty Chemicals Sell-Off - CRDA?
Team Kalkine

Is Croda Stock Undervalued After the Specialty Chemicals Sell-Off - CRDA?

  • Jan 19, 2026
  •   | Read Time : 10 Mins
EDV Posted Retail Margin Shrink in H1 FY26 Amid Cost Pressures
Team Kalkine

EDV Posted Retail Margin Shrink in H1 FY26 Amid Cost Pressures

  • Jan 18, 2026
  •   | Read Time : 10 Mins
One Financial Services Stock Lifts FY26 Growth Outlook and Advances Dual Listing Plans- ZIP
Team Kalkine

One Financial Services Stock Lifts FY26 Growth Outlook and Advances Dual Listing Plans- ZIP

  • Jan 18, 2026
  •   | Read Time : 10 Mins
eToro Group Limited: Scalable Global Platform with Strong Fundamentals and Long-Term Growth Optionality
Team Kalkine

eToro Group Limited: Scalable Global Platform with Strong Fundamentals and Long-Term Growth Optionality

  • Jan 16, 2026
  •   | Read Time : 10 Mins
One NASDAQ Listed Application Software Company at Resistance Level: RIOT
Team Kalkine

One NASDAQ Listed Application Software Company at Resistance Level: RIOT

  • Jan 16, 2026
  •   | Read Time : 10 Mins

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions